Is preclinical data sharing the new norm?

Is preclinical data sharing the new norm? In our experience, it is certainly becoming more commonplace. However it is not yet standard practice and remains the preserve of special projects. In this paper we expound the benefits of sharing proprietary preclinical data using examples of successful initiatives. The main barriers to data sharing are then described, with suggestions for how these might be overcome. To maximise the benefits and minimise the risks involved, we suggest that organisations look to develop standard operating procedures for data sharing.